Literature DB >> 8417055

Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease.

G P Fazio1, R F Redberg, T Winslow, N B Schiller.   

Abstract

OBJECTIVES: The aim of this study was to test the hypothesis that atherosclerotic plaque in the thoracic aorta detected by transesophageal echocardiography is a marker for coronary artery disease.
BACKGROUND: Previous pathologic and roentgenographic studies have suggested a relation between aortic plaque and coronary artery disease but have lacked clinical utility.
METHODS: We performed transesophageal echocardiography on 61 patients (30 women and 31 men aged 22 to 83 years [mean 60 +/- 14]) who had previously undergone cardiac catheterization with coronary angiography. The clinical indications for angiography were angina (n = 26), valvular heart disease (n = 17), positive noninvasive evaluation for ischemia without angina (n = 6), postmyocardial infarction (n = 5), familial hypercholesterolemia (n = 4), coronary cameral fistula (n = 1), atrial myxoma (n = 1) and suspected aortic dissection (n = 1). All patients underwent transesophageal echocardiography with imaging of the thoracic aorta. The criteria used to diagnose atherosclerotic plaque on transesophageal echocardiography were the presence of linear or focal increased echo-density with lumen irregularity and thickening or calcification of the aortic intima.
RESULTS: In 41 of the 61 patients, obstructive coronary artery disease was detected by angiography in at least one vessel (> 50% left main coronary artery stenosis or > 70% stenosis in the left anterior descending, right coronary or left circumflex artery distribution). In 37 of the 41, atherosclerotic plaque was detected in the thoracic aorta by transesophageal echocardiography. Twenty of the 61 patients had normal coronary angiographic findings or nonobstructive lumen irregularities. In 2 of these 20 patients, plaque was detected in the thoracic aorta on transesophageal echocardiography. The presence of aortic plaque on transesophageal study had a sensitivity of 90% and a specificity of 90% for angiographically proved obstructive coronary artery disease. The positive predictive value of aortic plaque for obstructive coronary artery disease was 95% and the negative predictive value was 82%.
CONCLUSIONS: The detection of atherosclerotic plaque in the thoracic aorta by transesophageal echocardiography appears to be a marker for the identification of obstructive coronary artery disease and deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417055     DOI: 10.1016/0735-1097(93)90729-k

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

1.  Aortic and coronary atherosclerosis: a natural association?

Authors:  Ernst E van der Wall; Arnoud van der Laarse
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-27       Impact factor: 2.357

2.  Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Ashkan A Malayeri; Shunsuke Natori; Hossein Bahrami; Alain G Bertoni; Richard Kronmal; João A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2008-05-24       Impact factor: 2.778

3.  Pulse wave velocity correlates with aortic atherosclerosis assessed with transesophageal echocardiography.

Authors:  C Szmigielski; G Styczyński; M Sobczyńska; A Milewska; G Placha; A Kuch-Wocial
Journal:  J Hum Hypertens       Date:  2015-04-23       Impact factor: 3.012

4.  Thermal strain imaging: a review.

Authors:  Chi Hyung Seo; Yan Shi; Sheng-Wen Huang; Kang Kim; Matthew O'Donnell
Journal:  Interface Focus       Date:  2011-05-23       Impact factor: 3.906

5.  Carotid atherosclerosis does not predict coronary, vertebral, or aortic atherosclerosis in patients with acute stroke symptoms.

Authors:  Dionesia D Adraktas; Natasha Brasic; Andre D Furtado; Su-Chun Cheng; Karen Ordovas; Kimberly Chun; Jeffrey D Chien; Sarah Schaeffer; Max Wintermark
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

6.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

7.  Aortic wall thickness assessed by multidetector computed tomography as a predictor of coronary atherosclerosis.

Authors:  Martin Jeltsch; Oliver Klass; Stefan Klein; Sebastian Feuerlein; Andrik J Aschoff; Hans-Jürgen Brambs; Martin H Hoffmann
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-03       Impact factor: 2.357

8.  Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study.

Authors:  Sara Hägg; Josefin Skogsberg; Jesper Lundström; Peri Noori; Roland Nilsson; Hua Zhong; Shohreh Maleki; Ming-Mei Shang; Björn Brinne; Maria Bradshaw; Vladimir B Bajic; Ann Samnegård; Angela Silveira; Lee M Kaplan; Bruna Gigante; Karin Leander; Ulf de Faire; Stefan Rosfors; Ulf Lockowandt; Jan Liska; Peter Konrad; Rabbe Takolander; Anders Franco-Cereceda; Eric E Schadt; Torbjörn Ivert; Anders Hamsten; Jesper Tegnér; Johan Björkegren
Journal:  PLoS Genet       Date:  2009-12-04       Impact factor: 5.917

9.  Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study.

Authors:  Cesare Russo; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

10.  Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.

Authors:  László B Tankó; Gerong Qin; Peter Alexandersen; Yu Z Bagger; Claus Christiansen
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.